Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Supernus Pharmaceuticals (SUPN) Stock Looks Reasonable On Sales While Returns Look Strong - simplywall.st

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals stock hits all-time high at 546.17 USD - Investing.com

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals Announces FDA Approval of Pasatru for Adults With Fibrodysplasia Ossificans Progressiva - quiverquant.com

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Mirum Pharmaceuticals SVP, Global Controller Sold Shares Worth Over $4M - TradingView

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Jolanda Howe Sells 40,000 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock - MarketBeat

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals (NASDAQ:VRTX) Sets New 1-Year High - Here's What Happened - MarketBeat

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Exploring New Approaches to Gastroesophageal Adenocarcinoma – Jazz Pharmaceuticals - Oncodaily

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analysts - BioSpace

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade) - Seeking Alpha

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Rice Hall James & Associates LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Forecast: Analysts Think Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Business Prospects Have Improved Drastically - simplywall.st

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals (RYTM) Could Be 14% Undervalued Following Its CMO Appointment - simplywall.st

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - Here's Why - MarketBeat

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

The New Frontier of Pharmaceutical Growth - Mexico Business News

news.google.com · 20 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Supernus Pharmaceuticals (SUPN) Stock Looks Reasonable On Sales While Returns Look Strong - simplywall.st

Vertex Pharmaceuticals stock hits all-time high at 546.17 USD - Investing.com

Regeneron Pharmaceuticals Announces FDA Approval of Pasatru for Adults With Fibrodysplasia Ossificans Progressiva - quiverquant.com

Mirum Pharmaceuticals SVP, Global Controller Sold Shares Worth Over $4M - TradingView

Jolanda Howe Sells 40,000 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock - MarketBeat

Vertex Pharmaceuticals (NASDAQ:VRTX) Sets New 1-Year High - Here's What Happened - MarketBeat

Exploring New Approaches to Gastroesophageal Adenocarcinoma – Jazz Pharmaceuticals - Oncodaily

Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analysts - BioSpace

X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade) - Seeking Alpha

Rice Hall James & Associates LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Forecast: Analysts Think Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Business Prospects Have Improved Drastically - simplywall.st

Rhythm Pharmaceuticals (RYTM) Could Be 14% Undervalued Following Its CMO Appointment - simplywall.st

Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - Here's Why - MarketBeat

The New Frontier of Pharmaceutical Growth - Mexico Business News